Post mortem analysis of hepatic volume and lipid content by magnetic resonance imaging and spectroscopy in fixed murine neonates
Marc Jonuscheit,Celina Uhlemeyer,Benedict Korzekwa,Marten Schouwink,Soner Öner‐Sieben,Regina Ensenauer,Michael Roden,Bengt‐Frederik Belgardt,Vera B. Schrauwen‐Hinderling
DOI: https://doi.org/10.1002/nbm.5140
2024-04-02
NMR in Biomedicine
Abstract:MRI/MRS enables quantification of liver volume and hepatic lipid content in fixed neonatal mice, allowing to save the tissue for additional histological and molecular analyses. MRI/MRS‐based liver volume and hepatic lipid content of four widely used mouse strains (NMRI, C57Bl/6J, C57Bl/6N and CBA) were measured and validated by enzymatic triglyceride assay analysis. MRS‐derived hepatic lipid content strongly correlated with enzymatic triglyceride assay analysis (R2 = 0.795). Maternal obesity and hyperglycemia are linked to an elevated risk for obesity, diabetes, and steatotic liver disease in the adult offspring. To establish and validate a noninvasive workflow for perinatal metabolic phenotyping, fixed neonates of common mouse strains were analyzed postmortem via magnetic resonance imaging (MRI)/magnetic resonance spectroscopy (MRS) to assess liver volume and hepatic lipid (HL) content. The key advantage of nondestructive MRI/MRS analysis is the possibility of further tissue analyses, such as immunohistochemistry, RNA extraction, and even proteomics, maximizing the data that can be gained per individual and therefore facilitating comprehensive correlation analyses. This study employed an MRI and 1H‐MRS workflow to measure liver volume and HL content in 65 paraformaldehyde‐fixed murine neonates at 11.7 T. Liver volume was obtained using semiautomatic segmentation of MRI acquired by a RARE sequence with 0.5‐mm slice thickness. HL content was measured by a STEAM sequence, applied with and without water suppression. T1 and T2 relaxation times of lipids and water were measured for respective correction of signal intensity. The HL content, given as CH2/(CH2 + H2O), was calculated, and the intrasession repeatability of the method was tested. The established workflow yielded robust results with a variation of ~3% in repeated measurements for HL content determination. HL content measurements were further validated by correlation analysis with biochemically assessed triglyceride contents (R2 = 0.795) that were measured in littermates. In addition, image quality also allowed quantification of subcutaneous adipose tissue and stomach diameter. The highest HL content was measured in C57Bl/6N (4.2%) and the largest liver volume and stomach diameter in CBA (53.1 mm3 and 6.73 mm) and NMRI (51.4 mm3 and 5.96 mm) neonates, which also had the most subcutaneous adipose tissue. The observed effects were independent of sex and litter size. In conclusion, we have successfully tested and validated a robust MRI/MRS workflow that allows assessment of morphology and HL content and further enables paraformaldehyde‐fixed tissue‐compatible subsequent analyses in murine neonates.
radiology, nuclear medicine & medical imaging,biophysics,spectroscopy